Domestic antibiotic sales data in animal health are improving

(Photo: Pixabay)

Antibiotic-resistant pathogens are a serious public and animal health problem worldwide. Data on antibiotics used in veterinary medicine provide valuable information for the evaluation and planning of measures against antimicrobial resistance (AMR).

The 13th ESVAC report published on November 20, 2023 by the European Medicines Agency (EMA) contains antibiotic sales data for 2022 in 31 European countries

Thanks to the legislative strictures and animal health measures introduced in the EU member states, including in our country, the use of antibiotics in Europe has decreased significantly. Between 2011 and 2022, total sales decreased by 53% in the 25 continuously reporting countries, especially from the point of view of human health, the so-called in the case of critically important active substances.

Our country is still in fifth place in terms of the sold quantities of domestic live animals and animal products

At the same time, there was a 29% decrease compared to the previous year and a 42% decrease compared to 2011. The most frequently used active substances are still tetracyclines and penicillins. The proportion of critically important active substances also decreased, fluoroquinolones by 56%, colistin by 52%, 3-4. and second-generation cephalosporins closed with 31% lower sales volumes compared to the previous year. At the same time, the distribution of pharmaceutical forms still shows that in our country the sales of preparations suitable for mass treatment, oral solutions and medicinal premixes are the most significant. In the future, we must continue to strive to treat animals only in the most necessary cases, on the instructions of a veterinarian, preferably with a laboratory sensitivity test and individually. Preserving the effectiveness of antibiotics is the key to the joint protection of public and animal health, it is in the common interest of all of us!

Nébih